Dubensky Thomas W. 4
4 · Tempest Therapeutics, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Dubensky Thomas W.
DirectorPresident
Transactions
- Purchase
Common Stock
2022-01-07$4.78/sh+2,000$9,560→ 113,343 total
4 · Tempest Therapeutics, Inc. · Filed Jan 11, 2022
Common Stock